Search Results - Fitzthum, E.

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    A phase II study of gemcitabine plus carboplatin in platinum-sensitive, recurrent ovarian carcinoma

    A phase II study of gemcitabine plus carboplatin in platinum-sensitive, recurrent ovarian carcinoma by Kose, M.F., Sufliarsky, J., Beslija, S., Saip, P., Tulunay, G., Krejcy, K., Minarik, T., Fitzthum, E., Hayden, A., Melemed, A.

    Published in Gynecologic oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    2095 POSTER A randomized, open-label CECOG phase II study of dose-dense FEC 75 vs FEC 90 as adjuvant therapy in early breast cancer patients

    2095 POSTER A randomized, open-label CECOG phase II study of dose-dense FEC 75 vs FEC 90 as adjuvant therapy in early breast cancer patients by Kahan, S, Spanik, S, Wagnerova, M, Skacel, T, Planko, B, Fitzthum, E, Lindner, E, Soldatenkova, V, Zielinski, C.C, Brodowicz, T

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Safety and Efficacy of Percutaneous Neuromodulation Therapy in the Management of Subacute Radiating Low Back Pain

    Safety and Efficacy of Percutaneous Neuromodulation Therapy in the Management of Subacute Radiating Low Back Pain by Borg-Stein, Joanne, Seroussi, Richard E., Gomba, Lorraine, Meleger, Alec, Schmitt, Susan, Leep, Eric, Glassman, Jerel H., Revord, John, Condon, Joseph, Bensen, Elizabeth, Fitzthum, Jeffery E., Fowler, Bradford C., Gliner, Bradford E., Firlik, Andrew D.

    Published in Pain practice
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    165 Gemcitabine (G) plus carboplatin (C) in patients whose epithelial ovarian carcinomas (EOC) relapsed ≥ 6 months after platinum-containing first-line therapy: Preliminary results of a phase II study

    165 Gemcitabine (G) plus carboplatin (C) in patients whose epithelial ovarian carcinomas (EOC) relapsed ≥ 6 months after platinum-containing first-line therapy: Preliminary results... by Kose, F., Sufliarsky, J., Beslija, S., Saip, P., Krejcy, K., Minarik, T., Fitzthum, E., Tulunay, G., Melemed, A.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Chronic lymphocytic leukemia and second primary nonlymphoid malignancies: cytopathologic study of 17 cases

    Chronic lymphocytic leukemia and second primary nonlymphoid malignancies: cytopathologic study of 17 cases by Fitzthum, Alexander D., Wakely, Paul E.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: